Researchers have developed a new technique that uses a so-called “energy molecule” to trigger the release of anti-cancer drugs directly into cancer cells. It may be especially effective in breast cancer treatment.
The findings were published in the journal Nature Communications.
Once inside the cancer cells, the molecule, adenosine-5’-triphosphate (ATP), releases its “payload”: a collection of molecules embed with an anti-cancer drug called doxorubicin, which targets the nucleus of the cancer cell.